A trial of lansoprazole in refractory gastric ulcer

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 3, 1996, Pages 381-386

  Van Rensburg, C J ^a   Louw, J A ^b   Girdwood, A H ^b   Simjee, A E ^c   Marks, I N ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; ENDOSCOPY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ULCER; TREATMENT OUTCOME; ULCER HEALING; VERTIGO;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGE FACTORS; AGED; ANTI-ULCER AGENTS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RECURRENCE; SEX FACTORS; STOMACH ULCER; TREATMENT FAILURE;

EID: 0030004053     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-0673.1996.00381.x     Document Type: Article

References (22)

1. Barradell LB, Faulds D, McTavish D. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs (US) 1992; 44: 225-50.
2. Wormsley KG, Bardhan KD, Morgan AG, et al. Lansoprazole is more effective than ranitidine in the healing of gastric ulcer. Gut 1992; 33 (Suppl. 1): 548, (Abstract T190.)
3. Brunner GH, Arnold A, Hennig U, Fuchs W. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment Pharmacol Ther. 1993; 7 (Suppl 1): 51-5.
4. Brunner GH, Harke U. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment Pharmacol Ther 1994; 8 (Suppl. 1): 59-64.
5. Brunner GH, Creutzfeldt W, Harke U, Lamberts S. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high dose ranitidine treatment. Digestion 1988; 38: 80-90.
6. 2-receptor antagonists. Aliment Pharmacol Ther 1987; 1: 31-8.
7. 2-blocker resistant peptic ulcer. Yakuri to Chiryo 1991; 19: 953-66.
8. 2-resistant gastroduodenal ulcers. Gastroenterology 1988; 94 (Pt 2): A348. (Abstract.)
9. 2-receptor antagonists. Aliment Pharmacol Ther 1987; 1: 31-8.
10. 2-receptor antagonists. Gastroenterology 1985; 88: 1620.
11. Gardner M, Altman D. Statistics with Confidence - Confidence Intervals and Statistical Guidelines (1st edn). London: BMJ.
12. Misawa T, Chijiiwa Y, Imazono Y, Fujishima H, Nawada H. Effects of lansoprazole, a gastric proton pump inhibitor on endocrine function and healing in patients with peptic ulcer. Ther Res 1991; 12: 175-89.
13. 2-receptor antagonist-refractory ulcer: its pathophysiology and treatment. J Clin Gastroenterol 1991; 13 (Suppl. 1): 129-33.
14. Lanas AI, Remacha B, Esteva F, Sáinz R. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995; 109: 1124-33.
15. Makiyama K, Umene Y, Murata I, Izuno M, Hara K. Clinical study on therapeutic effect of an antiulcer agent, lansoprazole, on gastric ulcer: with special reference to serum gastrin concentrations. Yakuri to Chiryo 1991; 19: 307-25.
16. Danish Omeprazole Study Group. Relapse of gastric ulcers after treatment with omeprazole and cimetidine. A double-blind follow-up study. Scand J Gastroenterol 1989; 24: 557-60.
17. Brunner GH, Creutzfeldt W. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. Digestion 1990; 47 (Suppl. 1): 64-8.
18. Walan A, Bader J-P, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastic ulcer. N Engl J Med 1989; 320: 69-75.
19. Sontag SJ. Current status of maintenance therapy in peptic ulcer disease. Am J Gastroenterol 1988; 83: 607-17.
20. Penston J, Wormsley KG. Long-term maintenance treatment of gastric ulcers with ranitidine. Aliment Pharmacol Ther. 1990; 4: 339-55.
21. Berlin RG, Root J, Cook T. Noctural therapy with famotidine for 1 year is effective in preventing relapse of gastric ulcer. Aliment Pharmacol Ther 1991; 5: 161-71.
22. Alstead EM, Ryan FP, Holdsworth CD. Ranitidine in the prevention of gastric and duodenal ulcer relapse. Gut 1983; 24; 418-20.